| Literature DB >> 36148024 |
Ricardo Barrientos1, Carlos Sisniega1, Samanta Catueno1, Robin Hougen1, Ashley Hanna1, Utpal Bhalala1.
Abstract
We report a rare case of middle cerebral artery (MCA) stroke in a teenage girl with initial improvement, followed by progression to malignant MCA infarction, requiring an urgent decompressive hemicraniectomy (DHC). Additionally, we report improvement in all areas, including language, comprehension, and motor skills at discharge and the 4-month follow-up. This rare presentation highlights the importance of monitoring the neurological status of a patient with an MCA infarct for progression to a life-threatening malignant MCA infarct. This case report also highlights the importance of consideration of DHC for a favorable outcome of the MMCA infarction.Entities:
Year: 2022 PMID: 36148024 PMCID: PMC9489348 DOI: 10.1155/2022/6500488
Source DB: PubMed Journal: Case Rep Pediatr
Figure 1(a) : MRI brain WO contrast. An MRI of the brain showed an acute infarct without hemorrhage involving the left insula and territory of the left middle cerebral artery. (b) MRI brain W-WO contrast. There is a loss of appropriate signal intensity within the M1 segment of the left MCA for a length of appropriate 9 mm. There is a reconstitution of appropriate signal intensity distal to the aforementioned. There is diminutive signal intensity involving the supraclinoid aspect of the right ICA with appropriate reconstitution distally, which may be artifactual in nature as no restricted diffusion is seen within the right cerebral hemisphere. The parent branches, the ACAs, PCAs, basilar artery, and vertebral arteries appear without significant stenosis. (c) MRI angiogram with head WO contrast. There is a demonstration of restricted diffusion involving the left basal ganglia and portions of the left frontal, parietal, and temporal lobes.
Initial diagnostic workup.
| Study | Results |
|---|---|
| CBC | WBC 15.7 cells/L, HB 10.9 gm/dL |
| HCT 34.1 L/L, PLT 362 per microL | |
| CMP | Na+ 140 mEq/L, K+ 3.6 mEq/L, Ca 8.7 mg/dL |
| BUN 6 mg/dL, creatinine 0.42 mg/dL | |
| PT | 13.9 seconds |
| INR | 1 |
| APTT | 27 seconds |
| Fibrinogen | 357 mg/dL |
| Lipid panel | LDL 117 mg/dL/HDL 31 mg/dL |
| POCT glucose | 98 mmol/L |
| MTHFR, DNA | C667T- detected heterozygous |
| A1298 C—not detected | |
| Homocysteine total | 5.4 |
| Lactate level | 0.48 mmol/L |
| Protein C | 107 |
| Protein S functional | 95% |
| Lupus anticoagulation panel | Not detected |
| Antiphospholipid antibody panel | Negative |
| Factor leiden | Negative |
| Anti-ds DNA antibody | Negative |
| Sjogren's abs | Negative |
| Sickle cell screen | Negative |
| APC resistance | 2.5 |
| ATIII | 80% |
| Factor II, DNA | Negative |
| Antixa assay | 0.7 units/mL |
| Factor 8∗∗∗ | 214% |
| COVID-19 IgG/IgM antibody | Negative |
| Urine drug screen∗∗∗∗ | Benzodiazepine |
CBC= Complete blood count. CMP= Complete metabolic profile. PT= Prothrombin time. INR= International normalized ratio. APTT = Activated partial prothrombin time. POCT= Point of care testing. MTHFR, DNA = Methylenetetrahydrofolate reductase. Anti-Ds DNA = Anti-double stranded DNA. APC = Activated protein C. ATIII = Antithrombin III. AntiXa = Anti-factor Xa. This result is not associated with an increased risk for hyperhomocysteinemia. Low-normal, not clinically relevant. ∗∗∗Thrombophilia workup negative. ∗∗∗∗Received intravenous benzodiazepine for suspected seizure/agitation on initial presentation.
Figure 2(a) : CT scan head WO contrast. A large hypodensity of the left MCA territory, predominantly involving the left frontal lobe, basal ganglia, insula, and left temporoparietal lobes; worsened since the prior MRI study. There is a significant mass effect on the left lateral ventricle. There is an interval development of uncal herniation and anterior subfalcine measuring 7-8 mm towards the right. There is an obliteration of the suprasellar and perimesencephalic cisterns. (b) CT Scan head WO contrast.
Figure 3Timeline of patient course throughout hospitalization.